| Item Type | Name |
|
Concept
|
Athletes
|
|
Academic Article
|
Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.
|
|
Academic Article
|
The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Arrhythmogenic Mitral Valve Prolapse Revisited: A Not Uncommon Cause of Youthful Sudden Death in Athletes and Women.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Counterpoint/Mandatory ECG screening of young competitive athletes.
|
|
Academic Article
|
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?
|
|
Academic Article
|
Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes.
|
|
Academic Article
|
Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years.
|
|
Academic Article
|
It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports.
|
|
Academic Article
|
Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.
|
|
Academic Article
|
Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities.
|
|
Academic Article
|
Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.
|
|
Academic Article
|
Recommendations for interpretation of 12-lead electrocardiogram in the athlete.
|
|
Academic Article
|
Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy.
|
|
Academic Article
|
Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities.
|
|
Academic Article
|
The editor's roundtable: sudden cardiac death in athletes.
|
|
Academic Article
|
Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear.
|
|
Academic Article
|
Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes?
|
|
Academic Article
|
Longevity in elite athletes: the first 4-min milers.
|
|
Academic Article
|
Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes.
|
|
Academic Article
|
Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes.
|
|
Academic Article
|
Incidence and causes of sudden death in U.S. college athletes.
|
|
Academic Article
|
Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning.
|
|
Academic Article
|
The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification.
|
|
Academic Article
|
Prevalence and clinical significance of left atrial remodeling in competitive athletes.
|
|
Academic Article
|
Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.
|
|
Academic Article
|
Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
|
|
Academic Article
|
Incidence of cardiovascular sudden deaths in Minnesota high school athletes.
|
|
Academic Article
|
Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry.
|
|
Academic Article
|
Ethics of preparticipation cardiovascular screening for athletes.
|
|
Academic Article
|
Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations.
|
|
Academic Article
|
Sickle cell trait associated with sudden death in competitive athletes.
|
|
Academic Article
|
Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
|
|
Academic Article
|
Sudden death in young athletes.
|
|
Academic Article
|
Epidemiology of sudden death in young, competitive athletes due to blunt trauma.
|
|
Academic Article
|
Outcomes in athletes with marked ECG repolarization abnormalities.
|
|
Academic Article
|
Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes.
|
|
Academic Article
|
Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle.
|
|
Academic Article
|
Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes.
|
|
Academic Article
|
To the editor--Participation screening for athletes.
|
|
Academic Article
|
Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.
|
|
Academic Article
|
Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field?
|
|
Academic Article
|
Shared decision-making in HCM.
|
|
Academic Article
|
National electrocardiography screening for competitive athletes: Feasible in the United States?
|
|
Academic Article
|
Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Perspectives on cardiovascular screening.
|
|
Academic Article
|
Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes.
|
|
Academic Article
|
Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
|
|
Academic Article
|
Does preparticipation cardiovascular screening of athletes save lives?
|
|
Academic Article
|
Cardiovascular screening for young athletes--reply.
|
|
Academic Article
|
Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes.
|
|
Academic Article
|
Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
|
|
Academic Article
|
Reply: To PMID 22809753.
|
|
Academic Article
|
Evolution in the process of screening United States high school student-athletes for cardiovascular disease.
|
|
Academic Article
|
Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players.
|
|
Academic Article
|
Electrocardiographic changes associated with training and discontinuation of training in an athlete with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology.
|
|
Academic Article
|
Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes.
|
|
Academic Article
|
Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes.
|
|
Academic Article
|
Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.
|
|
Academic Article
|
Counterpoint: Mandatory ECG screening of young competitive athletes.
|
|
Academic Article
|
Death in a young athlete due to commotio cordis despite prompt external defibrillation.
|
|
Academic Article
|
Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.
|
|
Academic Article
|
Letter by Maron et al Regarding Article, "Sudden Cardiac Death in National Collegiate Athletic Association Athletes".
|